Abingdon Health (LON:ABDX) Releases Quarterly Earnings Results

Abingdon Health (LON:ABDX) announced its quarterly earnings data on Monday. The company reported GBX (0.53) (($0.01)) earnings per share for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 20.72% and a negative return on equity of 62.56%.

Abingdon Health Trading Up 1.4 %

Shares of ABDX stock traded up GBX 0.09 ($0.00) during trading hours on Wednesday, reaching GBX 6.59 ($0.09). The company had a trading volume of 462,932 shares, compared to its average volume of 139,107. The firm has a market cap of £12.76 million, a price-to-earnings ratio of -16.02 and a beta of 0.13. The company has a 50 day moving average of GBX 7.46 and a 200 day moving average of GBX 7.96. The company has a debt-to-equity ratio of 46.64, a current ratio of 1.95 and a quick ratio of 1.96. Abingdon Health has a 1-year low of GBX 6 ($0.08) and a 1-year high of GBX 11.75 ($0.15).

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.